Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Balli

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Nanoscale|March 31, 2023
Solar cells based on 2D Janus group-III chalcogenide van der Waals heterostructuresM Bikerouin, O Chdil, M Balli
American Journal of Clinical Pathology|June 1, 1987
Follicular tumor in the sellar region without primary cancer of the thyroid. Heterotopic carcinoma?C Ruchti, M Balli-Antunes, H A Gerber
La Radiologia Medica|February 1, 1976
[Complications of pelvic radiotherapy of cervico-uterine carcinoma. Observations on case records from 1954 to 1968]M Balli, G Barbolini, M Morini, et al.
Dermatologica|January 1, 1988
Metastatic eccrine sweat gland carcinoma: case reportL Borradori, R Hertel, M Balli-Antunes, et al.
Tumori|October 31, 1988
Bleomycin, vincristine, mitomycin and cisplatin alternated with cyclophosphamide, 4'-epidoxorubicin and procarbazine in advanced non-small-cell lung cancerR Demicheli, G Bonciarelli, A Jirillo, et al.
Tumori|October 31, 1987
Phase II trial of mitomycin plus cisplatin in the treatment of advanced colorectal adenocarcinomaR Demicheli, A Jirillo, G Bonciarelli, et al.
Cell Death and Differentiation|July 21, 2001
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapyD Céfai, R Schwaninger, M Balli, et al.
La Radiologia Medica|November 1, 1989
[Peripheral lymphocyte populations in patients treated with pelvic and mediastinal radiotherapy]A Jirillo, M Balli, A Disperati, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Factors causing dose variability in drug administrationR Demicheli, A Jirillo, G Bonciarelli, et al.
Tumori|June 30, 1989
4'epidoxorubicin plus verapamil in anthracycline--refractory cancer patientsR Demicheli, A Jirillo, G Bonciarelli, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nanoscale|March 31, 2023
Solar cells based on 2D Janus group-III chalcogenide van der Waals heterostructuresM Bikerouin, O Chdil, M Balli
American Journal of Clinical Pathology|June 1, 1987
Follicular tumor in the sellar region without primary cancer of the thyroid. Heterotopic carcinoma?C Ruchti, M Balli-Antunes, H A Gerber
La Radiologia Medica|February 1, 1976
[Complications of pelvic radiotherapy of cervico-uterine carcinoma. Observations on case records from 1954 to 1968]M Balli, G Barbolini, M Morini, et al.
Dermatologica|January 1, 1988
Metastatic eccrine sweat gland carcinoma: case reportL Borradori, R Hertel, M Balli-Antunes, et al.
Tumori|October 31, 1988
Bleomycin, vincristine, mitomycin and cisplatin alternated with cyclophosphamide, 4'-epidoxorubicin and procarbazine in advanced non-small-cell lung cancerR Demicheli, G Bonciarelli, A Jirillo, et al.
Tumori|October 31, 1987
Phase II trial of mitomycin plus cisplatin in the treatment of advanced colorectal adenocarcinomaR Demicheli, A Jirillo, G Bonciarelli, et al.
Cell Death and Differentiation|July 21, 2001
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapyD Céfai, R Schwaninger, M Balli, et al.
La Radiologia Medica|November 1, 1989
[Peripheral lymphocyte populations in patients treated with pelvic and mediastinal radiotherapy]A Jirillo, M Balli, A Disperati, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Factors causing dose variability in drug administrationR Demicheli, A Jirillo, G Bonciarelli, et al.
Tumori|June 30, 1989
4'epidoxorubicin plus verapamil in anthracycline--refractory cancer patientsR Demicheli, A Jirillo, G Bonciarelli, et al.
Pageof 4